BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29070272)

  • 1. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.
    Dollner R; Lorentz Larsen P; Dheyauldeen S; Steinsvåg S
    Allergy Rhinol (Providence); 2017 Oct; 8(3):148-156. PubMed ID: 29070272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA; Jacobsen C; Christensen ME
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Life Effectiveness of MP-AzeFlu (Dymista
    Stjärne P; Nguyen DT; Kuhl HC
    Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of allergic rhinitis with MP-AzeFlu: a noninterventional study of a Swedish cohort.
    Stjarne P; Strand V; Theman K; Ehnhage A
    Rhinology; 2019 Aug; 57(4):279-286. PubMed ID: 30938376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
    BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.
    Klimek L; Bachert C; Stjärne P; Dollner R; Larsen P; Haahr P; Agache I; Scadding G; Price D
    Allergy Asthma Proc; 2016 Sep; 37(5):376-86. PubMed ID: 27657521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R; Nguyen DT; Kuhl HC
    Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I; Doros IC; Leru PM; Bucur I; Poenaru M; Sarafoleanu C
    Rhinology; 2018 Mar; 56(1):33-41. PubMed ID: 28942457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
    Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu
    Marth K; Renner A; Langmayr G; Pohl W; Nguyen DT; Kuhl HC
    Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
    Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
    van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
    J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
    Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
    Klimek L; Bachert C; Mösges R; Munzel U; Price D; Virchow JC; Wahn U; Bousquet J
    Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM
    J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
    Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.